Ex-Dentist Cited For Pain Research

Bristol-Myers Squibb Co. has presented its second annual Award for Distinguished Achievement in Pain Research to Ronald Dubner. Dubner, 55, is chief of the Neurobiology and Anesthesiology Branch of the National Institute, of Dental Research at the National Institutes of Health, Bethesda, Md.. Dubner was the first to identify specific pain-sensing cells (nociceptors) and their connections to the central nervous system. Prior to his work, it had been believed that the nerves in the skin respond

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Bristol-Myers Squibb Co. has presented its second annual Award for Distinguished Achievement in Pain Research to Ronald Dubner. Dubner, 55, is chief of the Neurobiology and Anesthesiology Branch of the National Institute, of Dental Research at the National Institutes of Health, Bethesda, Md..

Dubner was the first to identify specific pain-sensing cells (nociceptors) and their connections to the central nervous system. Prior to his work, it had been believed that the nerves in the skin responded to both painful and nonpainful stimuli.

Dubner also has found, in examining the effects of injury on the central nervous- system, that injury caused the skin nociceptors to become more sensitive. As a result, the nociceptors send increased impulses to the dorsal horn on the spinal cord. In response to the increase in signals, the nerve cells on the dorsal horn become larger, thus amplifying the pain signal.

Dubner has participated in clinical research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies